- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04741217
Aerosolisation During Respiratory Procedures
February 10, 2021 updated by: Guy's and St Thomas' NHS Foundation Trust
A Proof of Concept Study to Evaluate Aerosol Generation During Non-Invasive Positive Pressure Respiratory Procedures
Currently, a major issue within respiratory medicine is undertaking procedures that generate aerosolisation with the concern of spreading infection, such as the SARS-COV-2/COVID-19 virus.
It is anecdotally reported that lung function testing and positive airways pressure devices used in clinical practice are aerosol generating procedures however the data to support this is limited.
With the advent of high-speed imaging systems that can capture and quantify particle size and velocity we aim to investigate the aerosol generation in routine non-invasive positive pressure respiratory procedures.
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
10
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Healthy subjects
Description
Inclusion Criteria:
- Age 18-80 years
- Healthy subjects with no active medical conditions or previous pneumothorax
- Cognitively and linguistically able to follow instructions given in English and provide informed consent
Exclusion Criteria:
- Significant respiratory, cardiac or neurological conditions or previous pneumothorax
- Smoking history greater than 10 pack years
- Acute illness at the time of assessment
- Allergies to latex, metals or local anaesthetic agents
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Characterisation of aerosolised respiratory droplets
Time Frame: 1 year
|
Performed using high-speed imaging and particle size counters
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
March 1, 2021
Primary Completion (Anticipated)
September 1, 2021
Study Completion (Anticipated)
September 1, 2021
Study Registration Dates
First Submitted
February 3, 2021
First Submitted That Met QC Criteria
February 3, 2021
First Posted (Actual)
February 5, 2021
Study Record Updates
Last Update Posted (Actual)
February 15, 2021
Last Update Submitted That Met QC Criteria
February 10, 2021
Last Verified
August 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 288629
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
IPD Plan Description
Anonymised data may be shared based upon consideration of reasonable requests from researchers with a stated objective.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Tract Infections
-
Vakzine Projekt Management GmbHFGK Clinical Research GmbHUnknownInfection, Respiratory TractGermany
-
GlaxoSmithKlineCompletedInfections, Respiratory TractUnited States
-
GlaxoSmithKlineCompletedInfections, Respiratory TractGermany
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedInfections, Respiratory TractUnited States
-
GlaxoSmithKlineCompletedInfections, Respiratory TractAustralia
-
GlaxoSmithKlineCompletedInfections, Respiratory Tract
-
GlaxoSmithKlineCompletedInfections, Respiratory TractUnited States
-
GlaxoSmithKlineCompletedInfections, Respiratory Syncytial VirusUnited States
-
GlaxoSmithKlineCompletedInfections, Respiratory Syncytial VirusCanada
Clinical Trials on Not an interventional study
-
Boston Children's HospitalCompleted
-
University of British ColumbiaActive, not recruitingMyocardial Injury | Chronic Kidney Diseases | SurgeryCanada
-
University of British ColumbiaActive, not recruitingMyocardial Injury | Complication,Postoperative | Non-cardiac Surgery | High-sensitivity TroponinCanada
-
University of Texas Southwestern Medical CenterNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Recruiting
-
University of California, RiversideUniversity of South FloridaUnknownAging | Hiv | IncentivesUnited States
-
University of OxfordImanova Centre for Imaging SciencesCompleted
-
Queen Mary University of LondonActive, not recruiting
-
University of British ColumbiaCompletedPain | Pain, Postoperative | Surgery | Orthopedic Procedures | Ambulatory Surgical Procedures | Nerve BlockCanada
-
Danone Asia Pacific Holdings Pte, Ltd.CompletedImmunologic Activity Alteration
-
University of AthensKing's College Hospital NHS Trust; Charite University, Berlin, Germany; University...Not yet recruiting